Improved Cardiovascular Disease hEALth Service Delivery in Australia: Cluster Randomised Controlled Trial (IDEAL Study)

NACompletedINTERVENTIONAL
Enrollment

2,761

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

September 23, 2024

Study Completion Date

September 23, 2024

Conditions
Cardiovascular Diseases
Interventions
DIAGNOSTIC_TEST

Cardiovascular disease risk assessment

Intervention in which the addition of guideline-recommended absolute cardiovascular disease risk assessment is embedded into point-of-care blood collection services for cholesterol measurement and results (including risk score) are reported to referring doctors.

DIAGNOSTIC_TEST

Usual care assessment

Usual care in which blood cholesterol results are reported to referring doctors

Trial Locations (1)

7000

Menzies Institute for Medical Research, Hobart

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Diagnostic Services Pty Ltd

UNKNOWN

collaborator

Department of Health, Tasmania

OTHER_GOV

collaborator

Primary Health Tasmania

UNKNOWN

collaborator

National Heart Foundation, Australia

OTHER

collaborator

Healthcare Software Pty Ltd

UNKNOWN

collaborator

Uscom Limited

UNKNOWN

lead

Menzies Institute for Medical Research

OTHER